Documentation
Vendor-supplied data
COA stated as available
Not independently documented
Checked
Jul 18, 2026
Endocrine
Also known as: Pitocin Β· Syntocinon Β· OT
A hormone approved as an injectable obstetric medicine. Its popular 'bonding' and social-cognition uses are intranasal and unapproved, with inconsistent trial evidence.
Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.
Oxytocin is a nine-amino-acid peptide hormone produced in the hypothalamus and released by the posterior pituitary, and it is also manufactured synthetically. As a licensed drug it is used intravenously or intramuscularly in obstetric care. Separately, an intranasal form is used only in research into social and psychiatric effects.
Efficacy is well established and approved for its obstetric indications. For the popular behavioural uses β intranasal oxytocin for autism, trust, or social cognition β the evidence is inconsistent: a meta-analysis of randomised trials (Psychoneuroendocrinology, 2018) found at most small effects and largely inconclusive results, limited by small samples and heterogeneity.
Intravenous obstetric use carries significant risks, including uterine hyperstimulation, water intoxication with hyponatraemia, and adverse fetal effects, and is only appropriate under medical supervision. Intranasal research doses are generally reported to cause mild, transient effects, but that form is not a licensed product.
An approved prescription medicine in the EU and US for obstetric use β induction or augmentation of labour and control of postpartum bleeding β administered under medical supervision. The widely discussed intranasal and behavioural uses are not approved and remain investigational. Prescription-only.
Vendor comparison
The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.
Documentation
Vendor-supplied data
COA stated as available
Not independently documented
Checked
Jul 18, 2026
Affiliate disclosure: This page contains affiliate links. peptides.cx may receive a commission when a purchase is made through one of these links. Evidence ratings, safety summaries and editorial content are produced independently from vendor relationships.
Oxytocin is a nine-amino-acid peptide hormone produced in the hypothalamus and released by the posterior pituitary, and it is also manufactured synthetically. As a licensed drug it is used intravenously or intramuscularly in obstetric care. Separately, an intranasal form is used only in research into social and psychiatric effects.
Oxytocin is a nine-amino-acid peptide hormone produced in the hypothalamus and released by the posterior pituitary gland, and it is also manufactured synthetically for medical use. As a licensed drug β sold under names such as Pitocin and Syntocinon β it is given intravenously or intramuscularly in obstetric care. Quite separately, an intranasal form of oxytocin is used in research into social, cognitive, and psychiatric effects, which is the source of its popular reputation as a 'love hormone.' It is a prescription-only medicine, and the two contexts should not be confused.
The honest evidence picture splits along those same lines. For its approved obstetric indications β inducing or augmenting labour and controlling bleeding after birth β oxytocin's efficacy is well established and is the basis for its regulatory approval. For the behavioural uses that drive most online interest, the evidence is far weaker: a meta-analysis of randomized trials of intranasal oxytocin (Psychoneuroendocrinology, 2018) found at most small effects and largely inconclusive results, limited by small samples and study-to-study heterogeneity. Those intranasal and behavioural applications β for autism, trust, or social cognition β are not approved and remain investigational.
Safety also depends heavily on context. Intravenous obstetric use carries significant risks, including uterine hyperstimulation, water intoxication with hyponatraemia, and adverse effects on the fetus, and it is appropriate only under medical supervision. Intranasal research doses are generally reported to cause mild, transient effects such as headache or nasal irritation, but that form is not a licensed product. Because oxytocin is prescription-only in the EU and US, decisions about it belong with a qualified clinician. This page is an educational reference summarizing what the research shows; it is not medical advice, it is not a substitute for professional care, and it does not provide dosing, protocols, or sourcing guidance.
Evidence grade: A
Efficacy is well established and approved for its obstetric indications. For the popular behavioural uses β intranasal oxytocin for autism, trust, or social cognition β the evidence is inconsistent: a meta-analysis of randomised trials (Psychoneuroendocrinology, 2018) found at most small effects and largely inconclusive results, limited by small samples and heterogeneity. Extensively studied in animal models of pair-bonding, maternal behaviour, and social affiliation.
Efficacy is well established and approved for its obstetric indications. For the popular behavioural uses β intranasal oxytocin for autism, trust, or social cognition β the evidence is inconsistent: a meta-analysis of randomised trials (Psychoneuroendocrinology, 2018) found at most small effects and largely inconclusive results, limited by small samples and heterogeneity.
Extensively studied in animal models of pair-bonding, maternal behaviour, and social affiliation.
Intravenous obstetric use carries significant risks, including uterine hyperstimulation, water intoxication with hyponatraemia, and adverse fetal effects, and is only appropriate under medical supervision. Intranasal research doses are generally reported to cause mild, transient effects, but that form is not a licensed product.
An approved prescription medicine in the EU and US for obstetric use β induction or augmentation of labour and control of postpartum bleeding β administered under medical supervision. The widely discussed intranasal and behavioural uses are not approved and remain investigational. Prescription-only.